返回
AIM Vaccine Co., Ltd.（06660.HK）價格
06660.HK 股價走勢圖
AIM VACCINE (06660.HK)
AIM Vaccine Co., Ltd.
HK$3.69
-1.33%
$-0.05
休市： Jan 16, 16:00:00 HKT
暫無資料Earnings FAQ
06660.HK 最近的每股盈餘與預期相比如何？
AIM Vaccine Co., Ltd. 06660.HK 上一季度的收入表現如何？
AIM Vaccine Co., Ltd. 的收入預期是多少？
AIM Vaccine Co., Ltd. 的盈利品質評分是多少？
AIM Vaccine Co., Ltd. 何時發布財報？
AIM Vaccine Co., Ltd. 的預期收益是多少？
AIM Vaccine Co., Ltd. 是否超出收益預期？
關鍵數據
前收市價
$3.74
開盤價
$3.74
當日範圍
$3.67 - $3.78
52週區間
$3.03 - $6.55
交易量
535.0K
平均成交量
599.5K
每股盈餘 (TTM)
-0.26
股息收益率
--
市值
$1.8B
什麼是 AIM VACCINE？
AIM Vaccine Co., Ltd. engages in biological vaccine technology development, technology transfer, and technical services. The company is headquartered in Beijing, Beijing and currently employs 1,493 full-time employees. The company went IPO on 2022-10-06. The firm's commercialized products mainly include recombinant HBV vaccine, freeze dried human rabies vaccine, inactivated HAV vaccine, mumps vaccine, bivalent inactivated HFRS vaccine and Group A, C, Y and W135 MPSV. The firm's vaccine products under development include 13-Valent Pneumonia Conjugate Vaccine, 24-Valent Pneumonia Conjugate Vaccine, quadrivalent influenza virus vaccine, iterative serum-free rabies vaccine, mRNA shingles/herpes zoster vaccine, Iterative mRNA rabies vaccine, mRNA respiratory syncytial virus vaccine, novel-process highly-effective human diploid rabies vaccine, and others.